---
title: "Acetylcysteine - Amyloidosis - 2"
sidebar: mydoc_sidebar
permalink: db06151-mesh-d000686-2.html
toc: false 
---


Path ID: `DB06151_MESH_D000686_2`
{% include image.html url="images/db06151-mesh-d000686-2.png" file="db06151-mesh-d000686-2.png" alt="db06151-mesh-d000686-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000111 | acetylcysteine | Drug |
| CHEBI:15356 | cysteine | ChemicalSubstance |
| CHEBI:16856 | glutathione | ChemicalSubstance |
| MESH:D000686 | Amyloidosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Acetylcysteine | HAS METABOLITE | Cysteine |
| Cysteine | POSITIVELY CORRELATED WITH | Glutathione |
| Glutathione | NEGATIVELY CORRELATED WITH | Amyloidosis |
|---------|-----------|---------|

Comment: It's not clear how (or if at all) acetylcysteine can be used in the treatment of Amyloidosis. If so, it could be due to as a precursor in the formation of glutathione (https://en.wikipedia.org/wiki/Acetylcysteine#Chemistry), which in turn could have a role in depleting the occurrence of protein aggregation (https://pubmed.ncbi.nlm.nih.gov/15857408/, [https://pubmed.ncbi.nlm.nih.gov/33758187/).](https://pubmed.ncbi.nlm.nih.gov/33758187/).)

Reference: 
  - [https://en.wikipedia.org/wiki/Acetylcysteine#Pharmacodynamics](https://en.wikipedia.org/wiki/Acetylcysteine#Pharmacodynamics)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/12035#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/12035#section=Mechanism-of-Action)
